CRON Q3 2023 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$25M-12.0% YoY

Gross Profit

$4M16.0% margin

Operating Income

-$22M-87.8% margin

Net Income

-$2M-6.6% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+30.4%

Cash Flow

Operating Cash Flow

-$183,000

Free Cash Flow

-$508,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$45M

Stockholders' Equity

$1.5B

Cash & Equivalents

$776M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$28M	-12.0%
Gross Profit	$4M	$4M	-8.6%
Operating Income	-$22M	-$38M	+42.3%
Net Income	-$2M	-$51M	+96.8%

Revenue Segments

Cannabis Flower

$17M70%

Cannabis Extracts

$7M29%

Product and Service, Other

$128,0001%

Geographic Segments

CANADA

$19M76%

ISRAEL

$6M23%

Other Countries

$399,0002%